BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 1998;334 ( Pt 1):1-8. [PMID: 9693094 DOI: 10.1042/bj3340001] [Cited by in Crossref: 143] [Cited by in F6Publishing: 141] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Thymidine Phosphorylase in Cancer; Enemy or Friend? Cancer Microenviron 2016;9:33-43. [PMID: 26298314 DOI: 10.1007/s12307-015-0173-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
2 Grierson JR, Brockenbrough JS, Rasey JS, Wiens L, Vesselle H. Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP). Nucleosides Nucleotides Nucleic Acids 2010;29:49-54. [PMID: 20391192 DOI: 10.1080/15257770903451603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wang C, Weng Y, Wang H, Shi Y, Ma D. Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer. J Huazhong Univ Sci Technol [Med Sci ] 2010;30:494-9. [DOI: 10.1007/s11596-010-0456-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Charlesworth PJ, Harris AL. Mechanisms of Disease: angiogenesis in urologic malignancies. Nat Rev Urol 2006;3:157-69. [DOI: 10.1038/ncpuro0434] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
5 Hirano M, Martí R, Spinazzola A, Nishino I, Nishigaki Y. Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder. Nucleosides Nucleotides Nucleic Acids 2004;23:1217-25. [PMID: 15571233 DOI: 10.1081/NCN-200027485] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
6 Passantino L, Patruno R, Valerio P, Penna A, Mazzone F, Zito AF, Catalano V, Pellecchia A, Jirillo E, Ranieri G. Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. Immunopharmacol Immunotoxicol. 2005;27:95-107. [PMID: 15803863 DOI: 10.1081/iph-51753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Slama A, Lacroix C, Plante-Bordeneuve V, Lombès A, Conti M, Reimund JM, Auxenfants E, Crenn P, Laforêt P, Joannard A, Seguy D, Pillant H, Joly P, Haut S, Messing B, Said G, Legrand A, Guiochon-Mantel A. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab 2005;84:326-31. [PMID: 15781193 DOI: 10.1016/j.ymgme.2004.12.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
8 Re RN, Cook JL. An intracrine view of angiogenesis. Bioessays 2006;28:943-53. [PMID: 16937366 DOI: 10.1002/bies.20459] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
9 Valentino ML, Martí R, Tadesse S, López LC, Manes JL, Lyzak J, Hahn A, Carelli V, Hirano M. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS Lett 2007;581:3410-4. [PMID: 17612528 DOI: 10.1016/j.febslet.2007.06.042] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
10 Shahzad SA, Yar M, Khan ZA, Shahzadi L, Naqvi SAR, Mahmood A, Ullah S, Shaikh AJ, Sherazi TA, Bale AT, Kukułowicz J, Bajda M. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs. Bioorganic Chemistry 2019;85:209-20. [DOI: 10.1016/j.bioorg.2019.01.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
11 Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M. Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase. Journal of Biological Chemistry 2002;277:4128-33. [DOI: 10.1074/jbc.m111028200] [Cited by in Crossref: 171] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
12 Shahzad SA, Sarfraz A, Yar M, Khan ZA, Naqvi SAR, Naz S, Khan NA, Farooq U, Batool R, Ali M. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs. Bioorg Chem 2020;100:103876. [PMID: 32388426 DOI: 10.1016/j.bioorg.2020.103876] [Reference Citation Analysis]
13 Chung HY, Lee SJ, Lee JM, Huh S, Kim HK, Kwon OH, Lim HJ, Oh EJ, Kim TJ, O TM, Waner M. Expression Patterns of HIF-1α Under Hypoxia in Vascular Smooth Muscle Cells of Venous Malformations. Annals of Plastic Surgery 2015;75:332-7. [DOI: 10.1097/sap.0000000000000015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Asgari MM, Haggerty JG, McNiff JM, Milstone LM, Schwartz PM. Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors. J Cutan Pathol 1999;26:287-94. [PMID: 10472757 DOI: 10.1111/j.1600-0560.1999.tb01846.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
15 Albertsson P, Lennernäs B, Norrby K. Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis. Acta Oncol 2009;48:418-25. [PMID: 18932044 DOI: 10.1080/02841860802409512] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
16 Hirano M, Nishigaki Y, Martí R. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes. The Neurologist 2004;10:8-17. [DOI: 10.1097/01.nrl.0000106919.06469.04] [Cited by in Crossref: 114] [Cited by in F6Publishing: 90] [Article Influence: 6.7] [Reference Citation Analysis]
17 Edwards PN. A kinetic, modeling and mechanistic re-analysis of thymidine phosphorylase and some related enzymes: REVIEW ARTICLE. Journal of Enzyme Inhibition and Medicinal Chemistry 2008;21:483-518. [DOI: 10.1080/14756360600721075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li W, Chiba Y, Kimura T, Morioka K, Uesaka T, Ihaya A, Muraoka R. Transmyocardial laser revascularization induced angiogenesis correlated with the expression of matrix metalloproteinases and platelet-derived endothelial cell growth factor. Eur J Cardiothorac Surg 2001;19:156-63. [PMID: 11167105 DOI: 10.1016/s1010-7940(00)00649-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Perotti A, Locatelli A, Sessa C, Hess D, Viganò L, Capri G, Maur M, Cerny T, Cresta S, Rojo F. Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. J Clin Oncol. 2010;28:4554-4561. [PMID: 20855840 DOI: 10.1200/jco.2009.27.5867] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
20 Shin S, Bosc DG, Ingle JN, Spelsberg TC, Janknecht R. Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. J Cell Biochem 2008;105:866-74. [DOI: 10.1002/jcb.21884] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
21 Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol. 2003;21:421-427. [PMID: 12560429 DOI: 10.1200/jco.2003.10.103] [Cited by in Crossref: 117] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
22 Saada A. Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell Biol 2004;23:797-806. [PMID: 15684706 DOI: 10.1089/dna.2004.23.797] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
23 Brostjan C, Bayer A, Zommer A, Gornikiewicz A, Roka S, Benkö T, Yaghubian R, Jakesz R, Steger G, Gnant M, Friedl J, Stift A. Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. Cancer 2003;98:2291-301. [PMID: 14601101 DOI: 10.1002/cncr.11776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
24 Brockenbrough JS, Morihara JK, Hawes SE, Stern JE, Rasey JS, Wiens LW, Feng Q, Vesselle H. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation. J Histochem Cytochem 2009;57:1087-97. [PMID: 19654105 DOI: 10.1369/jhc.2009.952804] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
25 D'Angelo R, Boschetti E, Amore G, Costa R, Pugliese A, Caporali L, Gramegna LL, Papa V, Vizioli L, Capristo M, Contin M, Mohamed S, Cenacchi G, Lodi R, Morelli MC, Fasano L, Pisani L, Cescon M, Tonon C, Pinna AD, Dotti MT, Sicurelli F, Scarpelli M, Filosto M, Casali C, Pironi L, Carelli V, De Giorgio R, Rinaldi R. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020;267:3702-10. [PMID: 32683607 DOI: 10.1007/s00415-020-10051-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
26 Gillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am 2003;32:789-817, v. [PMID: 14562575 DOI: 10.1016/s0889-8553(03)00052-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
27 Uddin I, Taha M, Rahim F, Wadood A. Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase. Bioorganic Chemistry 2018;78:324-31. [DOI: 10.1016/j.bioorg.2018.03.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
28 Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev. 2009;29:903-953. [PMID: 19434693 DOI: 10.1002/med.20159] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 11.6] [Reference Citation Analysis]
29 Zhou J, Xiao YS, Tang ZY, Fan J, Wu ZQ, Zhao Y, Xue Q, Shen ZZ, Liu YK, Ye SL. Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration. J Cancer Res Clin Oncol 2005;131:547-51. [PMID: 15864645 DOI: 10.1007/s00432-005-0669-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Toyohara J, Fujibayashi Y. Trends in nucleoside tracers for PET imaging of cell proliferation. Nucl Med Biol. 2003;30:681-685. [PMID: 14499325 DOI: 10.1016/s0969-8051(03)00084-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
31 Shimaoka S, Matsushita S, Nitanda T, Matsuda A, Nioh T, Suenaga T, Nishimata Y, Akiba S, Akiyama S, Nishimata H. The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma. Cancer 2000;88:2220-7. [DOI: 10.1002/(sici)1097-0142(20000515)88:10<2220::aid-cncr4>3.0.co;2-c] [Cited by in Crossref: 33] [Article Influence: 1.6] [Reference Citation Analysis]
32 Mori S, Takao S, Ikeda R, Noma H, Mataki Y, Wang X, Akiyama S, Aikou T. Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity. Biochem Biophys Res Commun. 2002;295:300-305. [PMID: 12150947 DOI: 10.1016/S0006-291X(02)00662-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
33 Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Ozaki T, Hata K, Sakai E, Miyazaki K. Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase. Virchows Arch 2003;443:672-7. [PMID: 12910418 DOI: 10.1007/s00428-003-0866-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
34 Puthiamadathil JM, Weinberg BA. Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil. Cancer Manag Res 2017;9:461-9. [PMID: 29056855 DOI: 10.2147/CMAR.S113320] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ferraro P, Pontarin G, Crocco L, Fabris S, Reichard P, Bianchi V. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 2005;280:24472-80. [PMID: 15878850 DOI: 10.1074/jbc.M502869200] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
36 Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689-692. [PMID: 9924029 DOI: 10.1126/science.283.5402.689] [Cited by in Crossref: 597] [Cited by in F6Publishing: 519] [Article Influence: 27.1] [Reference Citation Analysis]
37 Sengupta S, Sellers LA, Matheson HB, Fan TP. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol 2003;139:219-31. [PMID: 12770927 DOI: 10.1038/sj.bjp.0705216] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
38 Uchida K, Danenberg PV, Danenberg KD, Grem JL. Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. BMC Cancer. 2008;8:386. [PMID: 19105824 DOI: 10.1186/1471-2407-8-386] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
39 Wang EH, Goh YB, Moon IS, Park CH, Lee KH, Kang SH, Kang CS, Choi YJ. Upregulation of thymidine phosphorylase in chronic glomerulonephritis and its role in tubulointerstitial injury. Nephron Clin Pract 2006;102:c133-42. [PMID: 16282698 DOI: 10.1159/000089672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
40 Javaid S, Ishtiaq M, Shaikh M, Hameed A, Choudhary MI. Thymidine esters as substrate analogue inhibitors of angiogenic enzyme thymidine phosphorylase in vitro. Bioorg Chem 2017;70:44-56. [PMID: 27955923 DOI: 10.1016/j.bioorg.2016.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 de Bruin M, Peters GJ, Oerlemans R, Assaraf YG, Masterson AJ, Adema AD, Dijkmans BA, Pinedo HM, Jansen G. Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cells. Mol Pharmacol 2004;66:1054-60. [PMID: 15269287 DOI: 10.1124/mol.104.000315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
42 Andleeb A, Dikici S, Waris TS, Bashir MM, Akhter S, Chaudhry AA, MacNeil S, Yar M. Developing affordable and accessible pro-angiogenic wound dressings; incorporation of 2 deoxy D-ribose (2dDR) into cotton fibres and wax-coated cotton fibres. J Tissue Eng Regen Med 2020;14:973-88. [PMID: 32473079 DOI: 10.1002/term.3072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 De Pinieux G, Flam T, Zerbib M, Taupin P, Bellahcène A, Waltregny D, Vieillefond A, Poupon MF. Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases. J Urol 2001;166:1924-30. [PMID: 11586262 DOI: 10.1097/00005392-200111000-00085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Liekens S, Bilsen F, De Clercq E, Priego EM, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase. FEBS Lett 2002;510:83-8. [PMID: 11755536 DOI: 10.1016/s0014-5793(01)03233-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
45 Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter KC. Thymidine phosphorylase expression in normal and hyperplastic endometrium. J Clin Pathol 2000;53:704-8. [PMID: 11041061 DOI: 10.1136/jcp.53.9.704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
46 Thiagarajan H, Thiyagamoorthy U, Shanmugham I, Dharmalingam Nandagopal G, Kaliyaperumal A. Angiogenic growth factors in myocardial infarction: a critical appraisal. Heart Fail Rev 2017;22:665-83. [PMID: 28639006 DOI: 10.1007/s10741-017-9630-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
47 Wang W, Yang J, Sun Y, Li Z, You C. Artificial ATP-Free in Vitro Synthetic Enzymatic Biosystems Facilitate Aldolase-Mediated C–C Bond Formation for Biomanufacturing. ACS Catal 2020;10:1264-71. [DOI: 10.1021/acscatal.9b04696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Oh T, El Kouni MH. Kinetics mechanism and regulation of native human hepatic thymidine phosphorylase. Int J Biochem Cell Biol 2019;110:122-9. [PMID: 30849523 DOI: 10.1016/j.biocel.2019.03.004] [Reference Citation Analysis]
49 Warfield BM, Matheson CJ, McArthur DG, Backos DS, Reigan P. Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation. ACS Chem Neurosci 2021;12:3477-86. [PMID: 34472849 DOI: 10.1021/acschemneuro.1c00494] [Reference Citation Analysis]
50 Backos DS, Fritz KS, McArthur DG, Kepa JK, Donson AM, Petersen DR, Foreman NK, Franklin CC, Reigan P. Glycation of glutamate cysteine ligase by 2-deoxy-d-ribose and its potential impact on chemoresistance in glioblastoma. Neurochem Res 2013;38:1838-49. [PMID: 23743623 DOI: 10.1007/s11064-013-1090-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
51 Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol. 1995;147:33-41. [PMID: 12085206 DOI: 10.1038/sj.bjc.6600315] [Cited by in Crossref: 189] [Cited by in F6Publishing: 168] [Article Influence: 9.9] [Reference Citation Analysis]
52 Marchetti S, Chazal M, Dubreuil A, Fischel JL, Etienne MC, Milano G. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis. Br J Cancer. 2001;85:439-445. [PMID: 11487278 DOI: 10.1054/bjoc.2001.1908] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rees M. The endometrium and hormone replacement: Safety and bleeding. British Menopause Society Journal 2000;6:6-9. [DOI: 10.1258/136218000771799432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Furukawa T, Tabata S, Yamamoto M, Kawahara K, Shinsato Y, Minami K, Shimokawa M, Akiyama SI. Thymidine phosphorylase in cancer aggressiveness and chemoresistance. Pharmacol Res 2018;132:15-20. [PMID: 29604437 DOI: 10.1016/j.phrs.2018.03.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
55 Boyle JJ, Wilson B, Bicknell R, Harrower S, Weissberg PL, Fan TP. Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol 2000;192:234-42. [PMID: 11004701 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH699>3.0.CO;2-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kumagai Y, Tachikawa T, Higashi M, Sobajima J, Takahashi A, Amano K, Fukuchi M, Ishibashi K, Mochiki E, Yakabi K, Tamaru J, Ishida H. Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma. Esophagus 2018;15:19-26. [DOI: 10.1007/s10388-017-0588-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Corelli F, Botta M, Lossani A, Pasquini S, Spadari S, Focher F. Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase. Il Farmaco 2004;59:987-92. [DOI: 10.1016/j.farmac.2004.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Li W, Yue H. Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends Cardiovasc Med 2018;28:157-71. [PMID: 29108898 DOI: 10.1016/j.tcm.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
59 Gbaj A, Edwards PN, Reigan P, Freeman S, Jaffar M, Douglas KT. Thymidine phosphorylase from Escherichia coli : Tight-binding inhibitors as enzyme active-site titrants. Journal of Enzyme Inhibition and Medicinal Chemistry 2008;21:69-73. [DOI: 10.1080/14756360500424010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
60 Gamez J, Lara MC, Mearin F, Oliveras-ley C, Raguer N, Olive M, Leist AT, Perello A, Perona M, Cervera C, Andreu AL, Martí R, Hirano M. A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. Journal of the Neurological Sciences 2005;228:35-9. [DOI: 10.1016/j.jns.2004.09.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
61 Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001;61:253-70. [PMID: 11172729 DOI: 10.1016/s0006-2952(00)00529-3] [Cited by in Crossref: 467] [Cited by in F6Publishing: 127] [Article Influence: 23.4] [Reference Citation Analysis]
62 Bonafé M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 2004;11:962-73. [DOI: 10.1038/sj.cdd.4401415] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 3.4] [Reference Citation Analysis]
63 Thanasai J, Limpaiboon T, Jearanaikoon P, Sripa B, Pairojkul C, Tantimavanich S, Miwa M. Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma. World J Gastroenterol 2010; 16(13): 1631-1638 [PMID: 20355241 DOI: 10.3748/wjg.v16.i13.1631] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
64 Heazell A, Brown M, Dunn W, Worton S, Crocker I, Baker P, Kell D. Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox Biomarkers. Placenta 2008;29:691-8. [DOI: 10.1016/j.placenta.2008.05.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
65 Rafi Z, Alouffi S, Khan MS, Ahmad S. 2’-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species. CPPS 2020;21:924-35. [DOI: 10.2174/1389203721666200213104446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Naz S, Farooq U, Ma H, Sarwar R, Riaz N. Three new acrylic acid derivatives from Achillea mellifolium as potential thymidine phosphorylase inhibitor: molecular docking and MD simulation studies. J Biomol Struct Dyn 2020;:1-12. [PMID: 32815797 DOI: 10.1080/07391102.2020.1808071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Yang Y, Padilla A, Zhang C, Labesse G, Kaminski PA. Structural characterization of the mammalian deoxynucleotide N-hydrolase Rcl and its stabilizing interactions with two inhibitors. J Mol Biol 2009;394:435-47. [PMID: 19822152 DOI: 10.1016/j.jmb.2009.10.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
68 De Clercq E. The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures. Med Res Rev 2011;31:118-60. [PMID: 19844936 DOI: 10.1002/med.20179] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
69 Zizzo N, Passantino G, D'alessio RM, Tinelli A, Lopresti G, Patruno R, Tricarico D, Maqoud F, Scala R, Zito FA, Ranieri G. Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer. Front Vet Sci 2019;6:368. [PMID: 31709268 DOI: 10.3389/fvets.2019.00368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Pyo H, Kim YB, Cho NH, Suh CO, Park TK, Yun YS, Kim GE. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. International Journal of Radiation Oncology*Biology*Physics 2005;62:725-32. [DOI: 10.1016/j.ijrobp.2004.10.044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
71 Lara MC, Valentino ML, Torres-torronteras J, Hirano M, Martí R. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Biochemical Features and Therapeutic Approaches. Bioscience Reports 2007;27:151-63. [DOI: 10.1007/s10540-007-9043-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
72 Schmidt MM, Greb H, Koliwer-Brandl H, Kelm S, Dringen R. 2-deoxyribose deprives cultured astrocytes of their glutathione. Neurochem Res 2010;35:1848-56. [PMID: 20734229 DOI: 10.1007/s11064-010-0251-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
73 Gunningham SP, Currie MJ, Morrin HR, Tan EY, Turley H, Dachs GU, Watson AI, Frampton C, Robinson BA, Fox SB. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. J Pathol 2007;212:335-44. [PMID: 17487938 DOI: 10.1002/path.2174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
74 Cao D, Ziemba A, McCabe J, Yan R, Wan L, Kim B, Gach M, Flynn S, Pizzorno G. Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity. Mol Cancer Ther 2011;10:2330-9. [PMID: 21954436 DOI: 10.1158/1535-7163.MCT-11-0202] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
75 Almandil NB, Taha M, Farooq RK, Alhibshi A, Ibrahim M, Anouar EH, Gollapalli M, Rahim F, Nawaz M, Shah SAA, Ahmed QU, Zakaria ZA. Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study. Molecules 2019;24:E1002. [PMID: 30871147 DOI: 10.3390/molecules24061002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Falcão de Campos C, Oliveira Santos M, Roque R, Conceição I, de Carvalho M. Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands. Case Rep Neurol Med 2019;2019:5976410. [PMID: 31885962 DOI: 10.1155/2019/5976410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
77 Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol. 2003;56:209-213. [PMID: 12610101 DOI: 10.1136/jcp.56.3.209] [Cited by in Crossref: 143] [Cited by in F6Publishing: 146] [Article Influence: 7.9] [Reference Citation Analysis]
78 Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K. Gene Expression for Dihydropyrimidine Dehydrogenase and Thymidine Phosphorylase Influences Outcome in Epithelial Ovarian Cancer. JCO 2000;18:3946-51. [DOI: 10.1200/jco.2000.18.23.3946] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
79 Martı́ R, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochemical and Biophysical Research Communications 2003;303:14-8. [DOI: 10.1016/s0006-291x(03)00294-8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
80 Tominaga T, Toi M, Ohashi Y, Abe O; 5'-BC Study Group. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients. Clin Breast Cancer 2002;3:55-64. [PMID: 12020396 DOI: 10.3816/cbc.2002.n.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
81 Haraguchi M, Tsujimoto H, Fukushima M, Higuchi I, Kuribayashi H, Utsumi H, Nakayama A, Hashizume Y, Hirato J, Yoshida H, Hara H, Hamano S, Kawaguchi H, Furukawa T, Miyazono K, Ishikawa F, Toyoshima H, Kaname T, Komatsu M, Chen ZS, Gotanda T, Tachiwada T, Sumizawa T, Miyadera K, Osame M, Yoshida H, Noda T, Yamada Y, Akiyama S. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol Cell Biol 2002;22:5212-21. [PMID: 12077348 DOI: 10.1128/MCB.22.14.5212-5221.2002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
82 Mcnally VA, Rajabi M, Gbaj A, Stratford IJ, Edwards PN, Douglas KT, Bryce RA, Jaffar M, Freeman S. Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylase. Journal of Pharmacy and Pharmacology 2007;59:537-47. [DOI: 10.1211/jpp.59.4.0008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
83 Schwartz PA, Vetticatt MJ, Schramm VL. Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase. Biochemistry 2011;50:1412-20. [PMID: 21222488 DOI: 10.1021/bi101900b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
84 Murray PE, Mcnally VA, Lockyer SD, Williams KJ, Stratford IJ, Jaffar M, Freeman S. Synthesis and enzymatic evaluation of pyridinium-Substituted uracil derivatives as novel inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry 2002;10:525-30. [DOI: 10.1016/s0968-0896(01)00309-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
85 Ikeda R, Furukawa T, Kitazono M, Ishitsuka K, Okumura H, Tani A, Sumizawa T, Haraguchi M, Komatsu M, Uchimiya H, Ren XQ, Motoya T, Yamada K, Akiyama S. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose. Biochem Biophys Res Commun 2002;291:806-12. [PMID: 11866437 DOI: 10.1006/bbrc.2002.6432] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
86 Akiyama S, Furukawa T, Sumizawa T, Takebayashi Y, Nakajima Y, Shimaoka S, Haraguchi M. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci. 2004;95:851-857. [PMID: 15546501 DOI: 10.1111/j.1349-7006.2004.tb02193.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
87 Ginsberg L, Schapira AH, Taanman J. Relapsing neuropathy in an 18-year-old woman. The Lancet Neurology 2007;6:192-8. [DOI: 10.1016/s1474-4422(07)70033-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
88 De Pinieux G, Flam T, Zerbib M, Taupin P, Bellahcène A, Waltregny D, Vieillefond A, Poupon M. BONE SIALOPROTEIN, BONE MORPHOGENETIC PROTEIN 6 AND THYMIDINE PHOSPHORYLASE EXPRESSION IN LOCALIZED HUMAN PROSTATIC ADENOCARCINOMA AS PREDICTORS OF CLINICAL OUTCOME: A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 43 CASES. Journal of Urology 2001;166:1924-30. [DOI: 10.1016/s0022-5347(05)65722-9] [Cited by in Crossref: 22] [Article Influence: 1.1] [Reference Citation Analysis]
89 Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter KC. Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis 1999;17:445-50. [PMID: 10651312 DOI: 10.1023/a:1006603709248] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
90 Hu CM, Chang ZF. Mitotic control of dTTP pool: a necessity or coincidence? J Biomed Sci 2007;14:491-7. [PMID: 17525869 DOI: 10.1007/s11373-007-9175-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
91 Pomeisl K, Horská K, Pohl R, Blažek J, Krečmerová M. Syntheses of 1-[2-(Phosphonomethoxy)Alkyl] thymine monophosphates and an evaluation of their inhibitory activity toward human thymidine phosphorylase. Nucleosides Nucleotides Nucleic Acids 2012;31:159-71. [PMID: 22356232 DOI: 10.1080/15257770.2011.648361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
92 Hayashi T, Wang XQ, Zhang HZ, Deguchi K, Nagotani S, Sehara Y, Tsuchiya A, Nagai M, Shoji M, Abe K. Induction of platelet derived-endothelial cell growth factor in the brain after ischemia. Neurol Res 2007;29:463-8. [PMID: 17535565 DOI: 10.1179/016164107X164139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
93 Salama RH, Fathalla MM, Mekki AR, Elsadek Bel-K. Implication of umbilical cord in preeclampsia. Med Princ Pract 2011;20:124-8. [PMID: 21252565 DOI: 10.1159/000321212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
94 Nishino I, Spinazzola A, Hirano M. MNGIE: from nuclear DNA to mitochondrial DNA. Neuromuscul Disord 2001;11:7-10. [PMID: 11166160 DOI: 10.1016/s0960-8966(00)00159-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
95 Suomalainen A, Kaukonen J. Diseases caused by nuclear genes affecting mtDNA stability. Am J Med Genet 2001;106:53-61. [DOI: 10.1002/ajmg.1379] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
96 Zhang X, Zheng Z, Shin YK, Kim KY, Rha SY, Noh SH, Chung HC, Jeung HC. Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer. Pathology. 2014;46:316-324. [PMID: 24798152 DOI: 10.1097/pat.0000000000000094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
97 Grem JL. Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer. Seminars in Oncology 2005;32:120-7. [DOI: 10.1053/j.seminoncol.2004.09.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
98 Bijnsdorp IV, Capriotti F, Kruyt FA, Losekoot N, Fukushima M, Griffioen AW, Thijssen VL, Peters GJ. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer 2011;104:1185-92. [PMID: 21386840 DOI: 10.1038/bjc.2011.74] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
99 Javaid S, Saad SM, Perveen S, Khan KM, Choudhary MI. 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors. Bioorg Chem 2015;63:142-51. [PMID: 26547232 DOI: 10.1016/j.bioorg.2015.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
100 Seckin I, Uzunalan M, Pekpak M, Kokturk S, Sonmez H, Oztürk Z, Demirci S, Yaprak E. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli. J Biomed Sci 2012;19:24. [PMID: 22335899 DOI: 10.1186/1423-0127-19-24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
101 Sessa C, Tosi D, Viganò L, Albanell J, Hess D, Maur M, Cresta S, Locatelli A, Angst R, Rojo F. Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel. Ann Oncol. 2010;21:1315-1322. [PMID: 19901013 DOI: 10.1093/annonc/mdp504] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
102 Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimar�es J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, Dimauro S, Hirano M. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 2000;47:792-800. [DOI: 10.1002/1531-8249(200006)47:6<792::aid-ana12>3.0.co;2-y] [Cited by in Crossref: 227] [Article Influence: 11.4] [Reference Citation Analysis]
103 Dredge K, Dalgleish AG, Marriott JB. Recent developments in antiangiogenic therapy. Expert Opinion on Biological Therapy 2005;2:953-66. [DOI: 10.1517/14712598.2.8.953] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
104 Garone C, Garcia-Diaz B, Emmanuele V, Lopez LC, Tadesse S, Akman HO, Tanji K, Quinzii CM, Hirano M. Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency. EMBO Mol Med 2014;6:1016-27. [PMID: 24968719 DOI: 10.15252/emmm.201404092] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
105 Fox SB, Gasparini G, Harris AL. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol 2001;2:278-89. [PMID: 11905783 DOI: 10.1016/S1470-2045(00)00323-5] [Cited by in Crossref: 155] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
106 Mori I, Yang Q, Kakudo K. Predictive and prognostic markers for invasive breast cancer. Pathol Int 2002;52:186-94. [DOI: 10.1046/j.1440-1827.2002.01335.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
107 Seregni E, Ferrari L, Martinetti A, Bombardieri E. Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol 2001;20:147-66. [PMID: 11398208 DOI: 10.1002/ssu.1028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
108 Dupouy C, Zhang C, Padilla A, Pochet S, Kaminski PA. Probing the active site of the deoxynucleotide N-hydrolase Rcl encoded by the rat gene c6orf108. J Biol Chem 2010;285:41806-14. [PMID: 20962348 DOI: 10.1074/jbc.M110.181594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
109 Liekens S, Hernández AI, Ribatti D, De Clercq E, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action. J Biol Chem 2004;279:29598-605. [PMID: 15123637 DOI: 10.1074/jbc.M402602200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
110 Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatric Clinics of North America 2002;49:203-19. [DOI: 10.1016/s0031-3955(03)00115-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
111 Vara D, Watt JM, Fortunato TM, Mellor H, Burgess M, Wicks K, Mace K, Reeksting S, Lubben A, Wheeler-Jones CPD, Pula G. Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis. Antioxid Redox Signal 2018;28:110-30. [PMID: 28793782 DOI: 10.1089/ars.2016.6869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
112 Ranieri G, Grammatica L, Patruno R, Zito AF, Valerio P, Iacobellis S, Gadaleta C, Gasparini G, Ribatti D. A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients. J Cell Mol Med 2007;11:362-8. [PMID: 17378915 DOI: 10.1111/j.1582-4934.2007.00007.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
113 Oh T, El Kouni MH. Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase. PLoS One 2018;13:e0202826. [PMID: 30138393 DOI: 10.1371/journal.pone.0202826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
114 Plasterer TN, Smith TF, Mohr SC. Survey of human mitochondrial diseases using new genomic/proteomic tools. Genome Biol 2001;2:RESEARCH0021. [PMID: 11423010 DOI: 10.1186/gb-2001-2-6-research0021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
115 Rooseboom M, Commandeur JN, Vermeulen NP. Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol Rev. 2004;56:53-102. [PMID: 15001663 DOI: 10.1124/pr.56.1.3] [Cited by in Crossref: 336] [Cited by in F6Publishing: 306] [Article Influence: 19.8] [Reference Citation Analysis]
116 Dikici S, Mangır N, Claeyssens F, Yar M, MacNeil S. Exploration of 2-deoxy-D-ribose and 17β-Estradiol as alternatives to exogenous VEGF to promote angiogenesis in tissue-engineered constructs. Regen Med 2019;14:179-97. [PMID: 30793662 DOI: 10.2217/rme-2018-0068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
117 Hague S, Manek S, Oehler MK, MacKenzie IZ, Bicknell R, Rees MC. Tamoxifen induction of angiogenic factor expression in endometrium. Br J Cancer 2002;86:761-7. [PMID: 11875740 DOI: 10.1038/sj.bjc.6600157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
118 Miszczak-Zaborska E, Kubiak R, Bieńkiewicz A, Bartkowiak J. The cytosol activity of thymidine phosphorylase in endometrial cancer. J Exp Clin Cancer Res 2008;27:64. [PMID: 18986516 DOI: 10.1186/1756-9966-27-64] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
119 Kim KW, Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Roh MH, Kim MC, Kim KH, Kim YH, Roh YH, Jeong JS, Kim HJ. Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapy. Mol Clin Oncol 2013;1:987-94. [PMID: 24649282 DOI: 10.3892/mco.2013.166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
120 Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M. Significance of membrane type 1 matrix metalloproteinase expression in breast cancer. Jpn J Cancer Res 1999;90:516-22. [PMID: 10391091 DOI: 10.1111/j.1349-7006.1999.tb00778.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
121 Guarcello V, Blanquicett C, Naguib FN, El Kouni MH. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity. Cancer Chemother Pharmacol 2008;62:85-96. [PMID: 17805539 DOI: 10.1007/s00280-007-0578-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
122 Hirano M, Lagier-Tourenne C, Valentino ML, Martí R, Nishigaki Y. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 2005;354:152-6. [PMID: 15975738 DOI: 10.1016/j.gene.2005.04.041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
123 Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 2001;15:981-94. [PMID: 11316792 DOI: 10.1101/gad.191101] [Cited by in Crossref: 176] [Cited by in F6Publishing: 173] [Article Influence: 8.8] [Reference Citation Analysis]
124 Schwartz PA, Vetticatt MJ, Schramm VL. Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase. J Am Chem Soc 2010;132:13425-33. [PMID: 20804144 DOI: 10.1021/ja105041j] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
125 Lim ST, Levine AM. Angiogenesis and hematological malignancies. Hematology 2013;10:11-24. [DOI: 10.1080/10245330400018409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
126 Votruba I, Pomeisl K, Tloust'ová E, Holý A, Otová B. Inhibition of thymidine phosphorylase (PD-ECGF) from SD-lymphoma by phosphonomethoxyalkyl thymines. Biochem Pharmacol 2005;69:1517-21. [PMID: 15857616 DOI: 10.1016/j.bcp.2005.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
127 Pula G, Garonna E, Dunn WB, Hirano M, Pizzorno G, Campanella M, Schwartz EL, El Kouni MH, Wheeler-Jones CP. Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate. Arterioscler Thromb Vasc Biol 2010;30:2631-8. [PMID: 20884872 DOI: 10.1161/ATVBAHA.110.215855] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
128 Yang Q, Barbareschi M, Mori I, Mauri F, Muscarà M, Nakamura M, Nakamura Y, Yoshimura G, Sakurai T, Caffo O, Galligioni E, Dalla Palma P, Kakudo K. Prognostic value of thymidine phosphorylase expression in breast carcinoma. Int J Cancer 2002;97:512-7. [PMID: 11802215 DOI: 10.1002/ijc.1633] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
129 Cavazzola LR, Carvalhal GF, Deves C, Renck D, Almeida R, Santos DS. Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue. Oncol Lett 2015;9:2886-94. [PMID: 26137165 DOI: 10.3892/ol.2015.3093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
130 Eisinger F, Patzelt J, Langer HF. The Platelet Response to Tissue Injury. Front Med (Lausanne) 2018;5:317. [PMID: 30483508 DOI: 10.3389/fmed.2018.00317] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
131 Henderson B, Martin ACR. Protein moonlighting: a new factor in biology and medicine. Biochemical Society Transactions 2014;42:1671-8. [DOI: 10.1042/bst20140273] [Cited by in Crossref: 77] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
132 Dikici S, Claeyssens F, MacNeil S. Bioengineering Vascular Networks to Study Angiogenesis and Vascularization of Physiologically Relevant Tissue Models in Vitro. ACS Biomater Sci Eng 2020;6:3513-28. [PMID: 32582840 DOI: 10.1021/acsbiomaterials.0c00191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
133 Sivridis E, Giatromanolaki A, Papadopoulos I, Gatter KC, Harris AL, Koukourakis MI. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer 2002;86:1465-71. [PMID: 11986782 DOI: 10.1038/sj.bjc.6600281] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
134 Martí R, Nishigaki Y, Vilá MR, Hirano M. Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders. Clin Chem Lab Med 2003;41:845-51. [PMID: 12940507 DOI: 10.1515/CCLM.2003.128] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
135 Capri M, Scarcella E, Bianchi E, Fumelli C, Mesirca P, Agostini C, Remondini D, Schuderer J, Kuster N, Franceschi C, Bersani F. 1800 MHz radiofrequency (mobile phones, different Global System for Mobile communication modulations) does not affect apoptosis and heat shock protein 70 level in peripheral blood mononuclear cells from young and old donors. International Journal of Radiation Biology 2009;80:389-97. [DOI: 10.1080/09553000410001702346] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
136 Hemalatha T, Balachandran C, Manohar BM, Nayeem M, Subramaniam S, Sharma HS, Puvanakrishnan R. Myocardial expression of PDECGF is associated with extracellular matrix remodeling in experimental myocardial infarction in rats. Biochem Cell Biol 2010;88:491-503. [PMID: 20555391 DOI: 10.1139/o09-165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
137 Buursma AR, van Dillen IJ, van Waarde A, Vaalburg W, Hospers GA, Mulder NH, de Vries EF. Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport. Br J Cancer 2004;91:2079-85. [PMID: 15599382 DOI: 10.1038/sj.bjc.6602216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
138 Cabrera-pérez R, Torres-torronteras J, Vila-julià F, Ortega FJ, Cámara Y, Barquinero J, Martí R. Prospective therapeutic approaches in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Expert Opinion on Orphan Drugs 2015;3:1167-82. [DOI: 10.1517/21678707.2015.1090307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
139 Javaid S, Shaikh M, Fatima N, Choudhary MI. Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies. PLoS One 2019;14:e0225056. [PMID: 31743355 DOI: 10.1371/journal.pone.0225056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
140 Verweij J, Disis ML, Cannistra SA. Phase I studies of drug combinations. J Clin Oncol 2010;28:4545-6. [PMID: 20855831 DOI: 10.1200/JCO.2010.30.6282] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
141 Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Hölscher AH, Danenberg PV, Brabender J. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer. Clin Lung Cancer 2010;11:328-34. [PMID: 20837458 DOI: 10.3816/CLC.2010.n.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]